Extensive Commercial Expertise and Proven Track Record of Success Tom O'Lenic's appointment marks a strategic move for RedShiftBio amidst rising…
Booth (#2500) will showcase AI-enabled innovations and digital solutions that enhance clinical decision making and provide personalized patient careORLANDO, Fla.--(BUSINESS…
Company Continues Expanding its Intellectual Property Footprint, Now has 14 US and 4 International PatentsSANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ:…
ANN ARBOR, MI / ACCESSWIRE / March 7, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…
DALLAS, March 07, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…
●Q4 and FY Revenue of $10.3 million and $40.2 million; a $8.4 million and 26% increase year-over-year ●Q4 and FY Income…
Aiding in the diagnosis of preterm pre-eclampsia and prognosis of delivery in symptomatic womenSAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq:QDEL) (“QuidelOrtho”), a…
NORTHAMPTON, MA / ACCESSWIRE / March 6, 2024 / A patient who goes often to a Patient Service Center (PSC)…
Dermalyser AI-driven support tool achieved remarkable sensitivity and specificity values of 95% and 85%, respectively, with these figures increasing to…
Submission supported by data from Phase 3 PERSEUS study, which showed the daratumumab subcutaneous formulation-based regimen significantly reduced the risk…